menu
    • menu

    Company profile for Generate Biomedicines

    NEW Drugs in Dev: 4
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Generate Biomedicines is a new kind of therapeutics company—existing at the intersection of machine learning, biological engineering, and medicine—pioneering Generative Biology™ to create breakthrough medicines. A fundamental shift in therapeutic development, driven by machine intelligence. Our machine learning algorithms analyze hundreds of millions of known proteins, looking for statistical patterns linking amino acid...
    Generate Biomedicines is a new kind of therapeutics company—existing at the intersection of machine learning, biological engineering, and medicine—pioneering Generative Biology™ to create breakthrough medicines. A fundamental shift in therapeutic development, driven by machine intelligence. Our machine learning algorithms analyze hundreds of millions of known proteins, looking for statistical patterns linking amino acid sequence, structure, and function.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Generate BiomedicinesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    26 Landsdowne Street Cambridge, MA 02139
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://generatebiomedicines.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/generate-biomedicines-inc
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/generate_biomed

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Generate Biomedicines to Present at Goldman Sachs Conference
    Generate Biomedicines to Present at Goldman Sachs Conference

    28 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/generate-biomedicines-inc-to-participate-in-goldman-sachs-47th-annual-global-healthcare-conference-302785001.html

    PR NEWSWIRE
    28 May 2026
    Share Share
    Generate Biomedicines Reports Q1 2026 Results and Update
    Generate Biomedicines Reports Q1 2026 Results and Update

    07 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/generate-biomedicines-inc-reports-first-quarter-2026-financial-results-and-provides-business-update-302765449.html

    PR NEWSWIRE
    07 May 2026
    Share Share
    Behind Generate's 'feverish' race to raise $400M IPO
    Behind Generate's 'feverish' race to raise $400M IPO

    27 Feb 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/generate-scores-largest-biotech-ipo-2024-400m-nasdaq-listing

    FIERCE BIOTECH
    27 Feb 2026
    Share Share
    Generate Plans $425M IPO To Bankroll Phase 3 Asthma Trials
    Generate Plans $425M IPO To Bankroll Phase 3 Asthma Trials

    23 Feb 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/generate-plans-425m-ipo-bankroll-antibodys-phase-3-asthma-trials

    FIERCE BIOTECH
    23 Feb 2026
    Share Share
    Generate Biomedicines Launches AI-Enhanced GB-0895 Trial
    Generate Biomedicines Launches AI-Enhanced GB-0895 Trial

    02 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/generatebiomedicines-to-initiate-global-phase-3-studies-of-gb-0895-a-long-acting-anti-tslp-antibody-for-severe-asthma-engineered-with-ai-302628234.html

    PR NEWSWIRE
    02 Dec 2025
    Share Share
    Flagship Brings AI Drug Discovery Firm Expedition Out Of Stealth
    Flagship Brings AI Drug Discovery Firm Expedition Out Of Stealth

    22 Oct 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/flagship-launches-another-ai-powered-drug-discovery-company-expedition-medicines

    FIERCE BIOTECH
    22 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search